Genetics in Medicine Publication: A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy
Max Catchpool, Dr Josh Knight and Dr Ilias Goranitis recently published a manuscript in the journal Genetics in Medicine. The article studies the relative cost-effectiveness of cascade genetic testing in asymptomatic relatives of patients with dilated cardiomyopathy (DCM). The study found that the addition of genetic testing to guide periodical clinical surveillance was very likely to be cost-effective and that testing should be offered to more patients with DCM than is currently recommended.
The study was a collaboration between the Health Economics Unit and Melbourne Genomics and made use of data collected as part of the Melbourne Genomics Health Alliance’s DCM study.
Further details and access to the article can be found here.
Image credit: https://commons.wikimedia.org/wiki/File:Herz-Heart.jpg